Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
15,717 results
- ITUIndependent statistical analysis of ITU Treatment for Chronic Epicondylitis Musculoskeletal Pain Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255733).
- IU-CHOICEIndependent statistical analysis of Indiana University Dementia Screening Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01699503).
- IUDIndependent statistical analysis of Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IUD@CSDIndependent statistical analysis of Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155738).
- IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400580).
- IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IV APAP SFIndependent statistical analysis of Analgesic Efficacy of Repeated Doses of Intravenous (IV) Acetaminophen in Post-operative Pediatric Spine Fusion Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: Complete Statistical AnalysisIndependent statistical analysis of IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- iVASTIndependent statistical analysis of The Intra-arterial Vasospasm Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01996436).
- Ivermectin and Human Immunity: Complete Statistical AnalysisIndependent statistical analysis of Ivermectin and Human Immunity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03459794).
- IVIDAIndependent statistical analysis of Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3: Complete Statistical AnalysisIndependent statistical analysis of IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03401073).
- IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff: Complete Statistical AnalysisIndependent statistical analysis of IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ivWatch Sensor: Device Validation for Infiltrated Tissues: Complete Statistical AnalysisIndependent statistical analysis of ivWatch Sensor: Device Validation for Infiltrated Tissues: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04064229).
- IVYIndependent statistical analysis of A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IWPIndependent statistical analysis of Immigrant Well-being Project: Transdisciplinary Ecological Mental Health Intervention for Mexican Immigrants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- IXORA-RIndependent statistical analysis of A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IXTENDIndependent statistical analysis of Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- JACOBIndependent statistical analysis of A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer: primary endpoint…
- JADE TEENIndependent statistical analysis of JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JakStat2Independent statistical analysis of Topical Interferon Gamma for Macular Edema Secondary to Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01376362).
- Janus Kinase Inhibition in Granuloma Annulare: Complete Statistical AnalysisIndependent statistical analysis of Janus Kinase Inhibition in Granuloma Annulare: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650736).
- Japanese AMLIndependent statistical analysis of Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Japanese IP-TN Trial: Complete Statistical AnalysisIndependent statistical analysis of Japanese IP-TN Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02831569).
- JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): Complete Statistical AnalysisIndependent statistical analysis of JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- JAWLINEIndependent statistical analysis of Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JET-ISRIndependent statistical analysis of JetStream Atherectomy for the Treatment of In-stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02730234).
- JETiIndependent statistical analysis of JETi Lower Extremity Arterial Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04370691).
- Jewel Electrophysiology (EP) Lab Study: Complete Statistical AnalysisIndependent statistical analysis of Jewel Electrophysiology (EP) Lab Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05490459).
- JintronixIndependent statistical analysis of A New Adaptive Physical Activity Technology in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02467491).
- JiVitA-3Independent statistical analysis of Antenatal Micronutrient Supplementation and Infant Survival: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00860470).
- JOTIndependent statistical analysis of Journey of Transformation Curriculum for Native American Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05274217).
- JPN ATO OLEIndependent statistical analysis of A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Jugular Venous Flow Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Jugular Venous Flow Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002494).
- Jump StartIndependent statistical analysis of Jump Start Shared Medical Appointments for Diabetes With Weight Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01973972).
- JUNGLEIndependent statistical analysis of Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- JUNIPERIndependent statistical analysis of Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JUNIPERIndependent statistical analysis of Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144: primary endpoint results, effect estimate with confidence interval, sample-size…
- Juno Perth Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Juno Perth Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02317042).
- Just Kwit: Mobile Intervention for Tobacco Cessation: Complete Statistical AnalysisIndependent statistical analysis of Just Kwit: Mobile Intervention for Tobacco Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538678).
- KALMARIndependent statistical analysis of Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01068873).
- KAMELEONIndependent statistical analysis of A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors: primary endpoint results, effect estimate with confidence…
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: Complete Statistical AnalysisIndependent statistical analysis of Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KAREIndependent statistical analysis of Ketamine for Reduction of Alcoholic Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02649231).
- KARISMA2Independent statistical analysis of KARISMA2, a randomized phase 2 trial evaluating low-dose tamoxifen for mammographic density reduction, including its non-inferiority framework, Wald testing, multiplicity adjustment, results, safety, and statistical interpretation.
- KATE2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced…
- KavaPKIndependent statistical analysis of Biomarker Changes and Anxiolytic Effects-Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565145).
- KEEP-PIndependent statistical analysis of Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers (KEEP-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03106636).